CSIMarket
 
Amedisys Inc  (NASDAQ: AMED)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $94.5000 $0.23 0.244%
Day's High: $94.88 Week Perf: 2.65 %
Day's Low: $ 94.00 30 Day Perf: 1.9 %
Volume (M): 361 52 Wk High: $ 98.95
Volume (M$): $ 34,152 52 Wk Avg: $93.79
Open: $94.00 52 Wk Low: $82.15



 Market Capitalization (Millions $) 3,131
 Shares Outstanding (Millions) 33
 Employees 19,000
 Revenues (TTM) (Millions $) 2,321
 Net Income (TTM) (Millions $) 83
 Cash Flow (TTM) (Millions $) 151
 Capital Exp. (TTM) (Millions $) 8

Amedisys Inc
Introduction:
Amedisys Inc. is a leading healthcare company that provides comprehensive home health services, hospice programs, personal care services, and care coordination services. Amedisys aims to improve patient outcomes and provide high-quality care services to patients in their homes. The company has a nationwide reach and provides a wide range of medical services to patients ranging from infants to elderly patients.

History:
Amedisys was incorporated in 1982, and it started its operations as a single-location hospice provider in Baton Rouge, Louisiana. The company's primary focus was on providing hospice services for terminally ill patients. Over the years, the company expanded its services and established home health services and personal care services. Today, the company has grown into a massive network of healthcare providers, serving patients across the United States.

Services:
Amedisys provides various services to ensure that patients receive the highest quality of home-based care. The company's home health services include skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, and other services aimed at helping patients recover from illnesses or injuries at home. The company's hospice services offer a comprehensive approach to end-of-life care, providing comfort and support to terminally ill patients and their families. Personal care services offered by Amedisys include non-medical assistance with daily living activities such as meal preparation, transportation, and companionship.

Operations:
Amedisys operates in 38 states in the United States, serving patients who need help to recover from illness or injury in their homes. The company has over 21,000 employees and a team of more than 4,000 clinicians, including registered nurses, physical therapists, occupational therapists, and social workers. Amedisys has a network of more than 330 care centers and offices throughout the United States, making it one of the most extensive home health care providers in the country.

Growth:
Over the years, Amedisys has grown exponentially, expanding its services and its geographic reach. The company has focused on mergers and acquisitions to achieve its growth objectives. The company has strategically acquired other home health providers and hospice providers to expand its footprint in the United States. For instance, in 2019, the company acquired Compassionate Care Hospice, a leading provider of hospice services, to expand its hospice services to more patients across the country.

Conclusion:
Amedisys is a leading healthcare provider that aims to provide high-quality care services to patients in their homes. The company's goal is to improve patient outcomes by providing personalized care, enhancing patient comfort, and improving overall quality of life. Amedisys provides various medical services, including home health services, hospice care, and personal care services, and operates in 38 states, serving patients across the United States. The company has grown into a massive healthcare network, and has expanded its services and operations through strategic acquisitions to meet the increasing demand for home health care services.


   Company Address: 3854 American Way Baton Rouge 70816 LA
   Company Phone Number: 292-2031   Stock Exchange / Ticker: NASDAQ AMED


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BKD     
EHC     
ENSG     
OPCH        4.53% 
SGRY        8.29% 
THC        10.62% 
• View Complete Report
   



Contract

Testing the Waters Amedisys Inc. Selected for Innovative Medicare Dementia Care Model Amidst Mixed Stock Performance

Published Wed, Aug 21 2024 10:30 AM UTC

In a significant development for the healthcare sector, Amedisys Inc. has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in an innovative new Medicare Dementia Care Model. This initiative aims to enhance care for patients living with dementia, a growing public health concern that currently affects millions of Americans.The selection unders...

Amedisys Inc

Amedisys Inc Reports a Steady 6.912% Revenue Increase in Q2 2024


Amedisys Inc.: A Transformative Quarter and a Strategic Partnership for Future Growth
In a significant turnaround, Amedisys Inc. (NASDAQ: AMED) reported positive earnings for the second quarter of 2024, delivering an earnings per share (EPS) of $0.98. This is a remarkable improvement compared to a loss of $2.46 per share during the same quarter last year, and a substantial 122.73% increase from the $0.44 EPS reported in the previous quarter. Amedisys has exhibited resilience, with net earnings reaching $32.573 million, a stark contrast to the net deficit of $80.481 million in the previous year's comparable period.

Financial Performance Highlights
Alongside the impressive earnings turnaround, Amedisys showcased solid revenue growth. Revenue for the second quarter surged by 6.91%, totaling $591.19 million compared to $552.97 million in the previous year?s quarter. Sequentially, revenue grew by 3.46% from $571.41 million in the previous quarter.
The company also highlighted its improving profit margins, as the net margin rose to 5.51% and the operating margin edged up to 8.83%. Operating earnings advanced significantly by 38.15%, reaching $52.214 million. These figures indicate not only a recovery but also an increasing efficiency in operations, which is critical for long-term sustainability and growth.

Amedisys Inc

Subheadline: Amedisys Inc. Faces Decline in Earnings Despite Revenue Growth in Q1 2024

Despite a revenue growth of 2.7% in the financial period ending March 31, 2024, Amedisys Inc. witnessed a significant income contraction of -42.86% compared to the same period the previous year. The company reported revenue of $571.41 million and earnings per share (EPS) of $0.44. Comparing these figures to the prior financial period, income decreased by -25.68% from $0.59 per share, while revenue increased only slightly by 0.11% from $570.79 million.
The bottom-line of $14.594 million in the first quarter of 2024 represented a decline of -41.41% from $24.909 million in the corresponding period in 2023. Amedisys Inc. focused on improving sales in this financial interval, which resulted in a net margin of 2.55%. Operating earnings also fell by -25.39% to $31.619 million, leading to a decrease in the operating margin from 7.62% to 5.53%.

Amedisys Inc

Amedisys Inc. Leads the Way in Healthcare Innovation with New Molecular Testing Partnership

The stock market can be a volatile and unpredictable place, with investors constantly seeking out opportunities for growth and stability. However, amidst the ups and downs, there are moments when companies stand out for their innovative approaches and potential for success. Amedisys, Inc., a leading provider of home health, hospice, and high-acuity care, has recently made a groundbreaking move that could have a significant impact on its future prospects.
Amedisys has partnered with Patient Choice Laboratories to offer advanced molecular testing across its care centers nationwide. This collaboration intends to revolutionize infection diagnosis by utilizing cutting-edge technology to swiftly and accurately identify pathogens in urine, respiratory, and wound infections. This move marks a significant step forward in the healthcare industry and showcases Amedisys' commitment to providing high-quality care to its patients.

Partnership

Amedisys Boosts Infection Diagnosis with Advanced Molecular Testing

Published Thu, Feb 8 2024 12:30 PM UTC

In a groundbreaking move, Amedisys, Inc., a leading provider of home health, hospice, and high-acuity care, has joined forces with Patient Choice Laboratories to offer advanced molecular testing across its care centers nationwide. This collaboration aims to revolutionize infection diagnosis by utilizing cutting-edge technology to swiftly and accurately identify pathogens in ...







Amedisys Inc's Segments
Home Health    63.32 % of total Revenue
Hospice    35.38 % of total Revenue
High Acuity Care    1.31 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com